Every betting line that moves on a phone during an NFL Sunday starts as a data feed. Someone has to collect that feed, verify it, and sell it to sportsbooks before the next snap.
Genius Sports (GENI) is one of the companies that does it. On Friday, Sept. 25, JPMorgan started coverage at Overweight, telling clients the shares look cheap. Its $8 price target implies 38% upside from the Thursday, Sept. 24, close, according to CNBC.
“Risk/reward skews positive here,” analyst Samuel Nielsen wrote, citing prediction market upside that Wall Street has not built into forecasts. He also pointed to improving free cash flow and growth that outpaces the market.
On Sept. 24, New York sued Polymarket, alleging it runs an illegal gambling operation, according to Bloomberg. Polymarket countersued the state hours later. Genius counts Polymarket as a partner, and its shares fell 5.2% to $5.80 that day, according to StockAnalysis data.
Genius is a small-cap stock worth about $1.71 billion. It offers exposure to betting’s growth without having to pick which app wins. It traded near $6.16 before the Sept. 24 opening bell and has ranged from $3.83 to $13.53 over the past year, according to StockAnalysis.
The longer view is harsher. Genius closed at a record $24.93 in May 2021, about a month after going public through a blank-check merger. The Sept. 24 close left the stock roughly 77% below that peak.
Wall Street is pricing a supplier like a sportsbook
Genius does not take bets. It supplies real-time data from live events to the sportsbooks that do, according to CNBC.
That position lets Genius sell to sportsbooks and prediction markets alike. It has partnered with Polymarket and Kalshi, according to its second-quarter earnings release. It also launched a prediction market comparison site on Sept. 17, according to a press release.
Yet the stock trades as if it carries a sportsbook’s risks. Shares have fallen 47% this year as sportsbooks lost ground to prediction markets, according to CNBC.
Thursday’s drop suggests investors are selling Genius on prediction market lawsuits, though those suits mostly threaten upside missing from forecasts.
StoneX noted that Genius’s 2026 guidance excludes NFL prediction market revenue and that fixed minimum guarantees protect its contracts, according to Investing.com.
Most analysts agree, but insiders have been selling
JPMorgan joins a crowded bull camp. Of the 22 analysts covering Genius, 19 rate it a Buy or Strong Buy, based on to LSEG data cited by CNBC. The average 12-month price target is about $11, nearly double the Sept. 24 close of $5.80.
Needham, Oppenheimer, Guggenheim, and Roth all lifted targets to $12 after August’s earnings, according to TipRanks. Wells Fargo went the other way, downgrading Genius to Equal Weight with an $8 target and citing execution risk and free cash flow.
Related: Kalshi, Polymarket bets are big problem for NFL
JPMorgan’s bullish target matches Wells Fargo’s neutral one. Wells Fargo acted on a day shares closed at $7.59, according to StockAnalysis data. JPMorgan is effectively making a similar price call on a stock about 24% cheaper.
Insiders have been sellers, too. They sold 850,000 shares over the past 90 days, according to MarketBeat, including 50,000 by CEO Mark Locke on Sept. 17. Such sales can reflect tax needs rather than a bearish view.
The Fed’s rate hike lands on the Legend debt
Part of this year’s damage traces to February. Genius agreed to buy Legend, owner of Covers.com and Casino.org, and its shares fell 27% that day, Sportico reported.
Investors balked at the hefty $1.2 billion price tag and questioned the strategic risk of a pure B2B data supplier suddenly shifting to own consumer-facing affiliate and media sites.
More JPMorgan:
- JPMorgan backs CoreWeave’s pricing play as a bear digs in
- JPMorgan sends strong message to Meta stock investors
- JPMorgan strongly recommends buying tumbling energy leader
To cover the $800 million upfront cash portion of the purchase, Genius took out an $825 million term loan that floats at a benchmark rate plus 3.5 percentage points, according to its May filing, cited by The Globe and Mail.
The Fed did so on Sept. 16, lifting its target range to 3.75% to 4%, according to its statement. By simple math, each quarter-point hike adds about $2 million a year in interest.
That is modest compared with the $285 million to $295 million in 2026 adjusted EBITDA, a measure of operating profit, that Genius forecast in its August earnings release. Higher rates hurt more through valuation, shrinking what investors pay for distant profits.
The data supplier may outlast the betting war
The legal fight over prediction markets has split the courts. The Third Circuit blocked New Jersey from applying its gambling law to Kalshi, while the Ninth Circuit let Nevada regulate such platforms like sportsbooks, The Hill reported.
StoneX sees possible Supreme Court review in 2027, according to Investing.com. It also notes curbs on prediction markets could push some bettors toward licensed sportsbooks that already buy Genius data.
The next checkpoint is November’s report, which Genius expects to include about $260 million in third-quarter revenue, according to its August release.
When regulators fight over who may take a bet, the company selling the official data may be the player that gets paid either way.
Related: Polymarket customer struggles to claw back funds lost to fraud
